Teva faces drug price fixing charges, to cut 350 jobs in Israel; Wintac gets hit by FDA Warning Letter | Radio Compass Blog
Teva plant tagged with warning letter for issues making schizophrenia drug | Fierce Pharma
Teva recalls U.S.-made drugs following contamination fears | Pittsburgh Post-Gazette
FDA issues warning about counterfeit Adderall purchased online | KATV
Teva, chasing Amgen's Aimovig, scores much-needed FDA approval for migraine drug Ajovy | Fierce Pharma
FDA WARNS CONSUMERS ABOUT COUNTERFEIT VERSION OF TEVA'S ADDERALL | East County Magazine
Teva's troubled Godollo plant earns firm US FDA warning letter
UPDATE 2-Teva halts output at U.S. drug plant after FDA flags concerns
Delays in drug approval cause further problems for Teva
Teva Pharmaceuticals
Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd. 4/5/17
FDA warning: some patients cannot process Plavix - The San Diego Union-Tribune
FDA issues counterfeit Adderall warning - PMLiVE
Teva stock drops on guidance, manufacturing problems - MarketWatch
FDA warns of Adderall shortage after Teva manufacturing delay
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CCBS56SBRRKUDM7JEVVE3UOQEE.jpg "Teva halts output at U.S. drug plant after FDA flags concerns | Reuters")
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
FDA warns of fake Adderall sales | wqad.com
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
FDA warns of Adderall shortage after Teva manufacturing delay - YouTube
Teva wants to join Big PhRMA with an ongoing FDA Import Alert for Deficient cGMP
Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Injection USP 5 mg/5 mL Due to the Presence of Particulate Matter | FDA
Teva's struggling sterile plant hit with FDA warning letter - Skyland Analytics
FDA Warning Letter Reveals Data and Sterility Issues at Teva Plant in Hungary | RAPS
Celltrion FDA warning causes headache for Teva's biologics ambition
